Grow your business by exhibiting your products at Heart Congress 2023

Heart Congress 2023 welcomes all the professionals from Medical Healthcare, Cardiologists, Surgeons, Medicine Specialists, Professors, Medical Researchers, Nurses and Nurse Practitioners, Fellow Scholars, Industrial Professionals, Physicians, Student Delegates and Exhibitors to our two-day event “12th World Heart Congress” scheduled on July 18-19, 2023 at Paris, France with a goal to empower healthcare providers.

Heart Congress 2023 with the theme “ Tuning the Rhythm of Cardiology ’’will be featuring the world class keynote talk, speakers presenting clinical studies, oral and poster presentation with interactive networking session and workshops.

The key objective of Conference is to provide a platform for all the medical professionals including students to discuss and learn about new innovations on cardiology research, clinical updates and new analysis with the cardiology and industrial experts to advance the ongoing research. The conference will focus on, Cardiovascular Disease, Risk factors and Nutrition, Catheterization and Cardiovascular Interventions, Cardio metabolic Health- Diabetes, Obesity & Metabolism, Acute Coronary Syndromes, Cardio-oncology, Geriatric Cardiology, Heart Failure and Cardiomyopathies, Cardiac Imaging, Coronary Heart Diseases, Cardiac Regeneration, Cardiac Pharmacology, Pulmonary Hypertension and Venous Thromboembolism, Interventional Cardiology and Heart Surgery, Current research on Cardiology - Future Medicine, Implantable cardioverter-defibrillator.

Heart Congress 2023 is one of the world's leading scientific conferences to bring together globally renowned cardiology healthcare practitioners, scientists, public health experts, academics, academic scientists, industry researchers, and scholars to share ideas. You will take advantage of seminars from business experts, scientific meetings, contact with members of the business, meeting attendees, and lunch and coffee break experiences. The goal of this meeting is to promote new therapeutic ideas and examine the existing demand for the potential direction of cardiovascular medications, equipment, and diagnostics, with a greater focus on new products that will be useful across the cardiology spectrum. We expect healthcare professionals from over 100 countries to be invited.

Highlighted Sessions:

Exhibitor/Sponsor Benefits:

An opportunity to sponsor one poster presentation award.
Complimentary conference registration.
Set up of one tailor-made exhibit booth (Booth Size 3x3 sqm).
Logo recognition on the conference website sponsorship page.
A4 Color Advertisement in Conference Proceedings.
Inclusion of your company’s Flyer/Logo in the conference delegate bags.
Exclusive online promotion on all our social Networking Sites.
Promote your corporate image through logo branding.
Brand briefing at the opening and closing ceremonies.
Press Release on behalf of your company.

Market Analysis Report : HEART CONGRESS 2023

The Cardiology & Cardiovascular Equipment Market Research Report gives a clear picture of the recent development of equipment in various business sectors. It also offers market forecasts for the coming years. The report profiles some of the leading players in the global market for the purpose of an in-depth study of the challenges facing the industry as well as the growth opportunities in the field. With the arrival of new medicines and devices on the market, the global cardiovascular therapeutics market is expected and all ready to grow and see rapid innovation. Diabetes, according to our market study, is one of the prominent and significant factors leading to the growing prevalence of modern cardiovascular disease. Global demand for cardiovascular equipment reached nearly $42.4 billion in 2017 and is forecast to hit $59.1 billion by 2022, with a compound annual growth rate ( CAGR) of 6.9% for the 2017-2022 period.

Cardiovascular surgical devices, cardiac rhythm control devices such as implantable cardiac defibrillators (ICDs), pacemakers Cardiac assist devices (CADs) such as ventricular aid devices, cardiac resynchronization therapy devices (CRTs), cardiac rhythm control devices such as implantable cardiac defibrillators (ICDs), pacemakers Cardiac assist devices (CADs) such as ventricular assist devices, cardiac resynchronization therapy devices (CRTs) Such as endovascular grafts, IVC filters and occlusion devices. The largest cause of death around the globe is cardiovascular diseases. In 2015, it accounted for 17.3 million casualties and is predicted to claim 23.6 million lives in 2030 (according to the World Health Organization 's prediction). It has been estimated by the International Federation of Diabetes that approx. 415 million people were diabetic in 2015 and it is projected to grow to 642 million worldwide by 2040. By 2020, global spending on illnesses such as cardiovascular diseases, cancer, and respiratory diseases is expected to reach $4 trillion. The global interventional cardiology market was valued at $14.69 billion in 2017 and is expected to hit $24.96 billion by 2027.

For more information: https://heartcongress.cardiologymeeting.com/

To submit abstract here: https://heartcongress.cardiologymeeting.com/abstract-submission.php

Dec 09, 2022

Author

Briana Wilson